AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17345916 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed feedback only
Number of subjects: 122
Study 17345916 — intervention group
Group type: EXPERIMENTAL
Intervention: MI with mailed feedback
Number of subjects: 122
Study 17345916 — intervention group
Group type: COMPARATOR
Intervention: Assessment only control
Number of subjects: 122
Study 17345916 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback (for females)
Number of subjects: 122
Study 17345916 — intervention group
Group type: EXPERIMENTAL
Intervention: MI (for females)
Number of subjects: 122
Study 12590890 — intervention group
Group type: EXPERIMENTAL
Intervention: QuicKlamp mechanical compression
Number of subjects: 100
Study 12590890 — intervention group
Group type: COMPARATOR
Intervention: Manual compression
Number of subjects: 100
Study 11196006 — intervention group
Group type: EXPERIMENTAL
Intervention: High expressed emotion (EE) relatives during family problem-solving interactions
Number of subjects: 47
Study 11196006 — intervention group
Group type: COMPARATOR
Intervention: Low expressed emotion (EE) relatives during family problem-solving interactions
Number of subjects: 47
Study 8824967 — intervention group
Group type: EXPERIMENTAL
Intervention: Single injection of diphtheria and tetanus toxoids and pertussis vaccine combined with inactivated poliovirus vaccine
Number of subjects: 84
Study 1486543 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (hydroxymethyl glutaryl coenzyme A reductase inhibitor)
Number of subjects: 600
Study 1486543 — intervention group
Group type: COMPARATOR
Intervention: Medical management only
Number of subjects: 600
Study 1486543 — intervention group
Group type: COMPARATOR
Intervention: Coronary bypass graft
Number of subjects: 600
Study 1486543 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty
Number of subjects: 600
Study 3976552 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-sparing-modified fast (PSMF)
Number of subjects: 16
Study 3976552 — intervention group
Group type: COMPARATOR
Intervention: Protein-formula-liquid diet
Number of subjects: 16
Study 3976552 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (PSMF and liquid diet)
Number of subjects: 16
Study 30860948 — intervention group
Group type: EXPERIMENTAL
Intervention: AS + RT + CT
Number of subjects: 612
Study 30860948 — intervention group
Group type: COMPARATOR
Intervention: AS + RT
Number of subjects: 612
Study 29910009 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofexidine (n=56)
Number of subjects: 111
Study 29910009 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (n=55)
Number of subjects: 111
Study 26877078 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based training (30 minutes, 6 days per week for 20 weeks)
Number of subjects: 101
Study 26877078 — intervention group
Group type: COMPARATOR
Intervention: Usual care (waitlist control)
Number of subjects: 101
Study 25278376 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily extended-release tacrolimus (LCPT)
Number of subjects: 543
Study 25278376 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily tacrolimus
Number of subjects: 543
Study 22639400 — intervention group
Group type: EXPERIMENTAL
Intervention: rhPTH (1-34)
Number of subjects: 124
Study 22639400 — intervention group
Group type: COMPARATOR
Intervention: elcatonin
Number of subjects: 124
Study 20143651 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine, 20 mg/d
Number of subjects: 21
Study 18982785 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital nerve block in the middle finger of the left hand
Number of subjects: 82
Study 18982785 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82
Study 16087838 — intervention group
Group type: EXPERIMENTAL
Intervention: Pupil ovalization after phakic intraocular lens implantation
Number of subjects: 12
Study 16087838 — intervention group
Group type: COMPARATOR
Intervention: Regular pupils (control group)
Number of subjects: 12
Study 12585164 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiangzhi Tiaoya Granule (JZTYG)
Number of subjects: 59
Study 10506719 — intervention group
Group type: EXPERIMENTAL
Intervention: Older urologists
Number of subjects: 1050
Study 10506719 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger urologists
Number of subjects: 1050
Study 10506719 — intervention group
Group type: COMPARATOR
Intervention: Urologist age
Number of subjects: 1050
Study 7503601 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose amphotericin B (total dose ≤ 500 mg)
Number of subjects: 427
Study 7503601 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose amphotericin B (total dose > 500 mg)
Number of subjects: 427
Study 7503601 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 427
Study 7503601 — intervention group
Group type: COMPARATOR
Intervention: Catheter-related candidemia (catheters retained)
Number of subjects: 427
Study 7503601 — intervention group
Group type: COMPARATOR
Intervention: Catheter-related candidemia (catheters removed)
Number of subjects: 427
Study 2048709 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 0.075 mg/kg i.v. given at induction of anesthesia after intubation (n = 20)
Number of subjects: 61
Study 2048709 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 0.075 mg/kg i.v. given during the last muscle suture (n = 21)
Number of subjects: 61
Study 2048709 — intervention group
Group type: COMPARATOR
Intervention: No antiemetic treatment (n = 20)
Number of subjects: 61
Study 6793303 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of prostaglandin F2 alpha (PGF2 alpha)
Number of subjects: 200
Study 6793303 — intervention group
Group type: COMPARATOR
Intervention: Oral quinine hydrochloride
Number of subjects: 200
Study 31391029 — intervention group
Group type: EXPERIMENTAL
Intervention: iCBT intervention consisting of six modules over 9 weeks
Number of subjects: 1050
Study 31391029 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 1050
Study 28867441 — intervention group
Group type: EXPERIMENTAL
Intervention: #standwithpp
Number of subjects: 30000
Study 28867441 — intervention group
Group type: COMPARATOR
Intervention: #defundpp
Number of subjects: 30000
Study 28867441 — intervention group
Group type: COMPARATOR
Intervention: #standwithpp and #defundpp
Number of subjects: 30000
Study 25553558 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (Transtheoretical Model workshops)
Number of subjects: 71
Study 25553558 — intervention group
Group type: COMPARATOR
Intervention: Control group (physical activity and open group-education regarding nutrition of usual care)
Number of subjects: 71
Study 24086259 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV-7 (wholly vaccinated villages)
Number of subjects: 16
Study 24086259 — intervention group
Group type: COMPARATOR
Intervention: Serogroup-C-meningococcal-conjugate-vaccine (partly vaccinated villages)
Number of subjects: 16
Study 21884603 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-based intervention: Unstructured materials with no obvious play value introduced to the playground
Number of subjects: 216
Study 21884603 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult-based intervention: Risk reframing sessions held with parents and teachers
Number of subjects: 216
Study 21884603 — intervention group
Group type: COMPARATOR
Intervention: Control group: Schools have recess as usual
Number of subjects: 216
Study 19694438 — intervention group
Group type: EXPERIMENTAL
Intervention: Yerba mate consumption (330 mL, 3 times/day for 40 days) in normolipidemic subjects
Number of subjects: 102
Study 19694438 — intervention group
Group type: EXPERIMENTAL
Intervention: Yerba mate intake by dyslipidemic individuals (330 mL, 3 times/day for 40 days)
Number of subjects: 102
Study 19694438 — intervention group
Group type: EXPERIMENTAL
Intervention: Yerba mate consumption by hypercholesterolemic individuals on statin therapy (330 mL, 3 times/day for 40 days)
Number of subjects: 102
Study 17240472 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (20-40mg orally once daily for 6 months)
Number of subjects: 36
Study 15616203 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 4047
Study 15616203 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventionally treated obese subjects)
Number of subjects: 4047
Study 11495267 — intervention group
Group type: EXPERIMENTAL
Intervention: Nested PCR
Number of subjects: 90
Study 11495267 — intervention group
Group type: EXPERIMENTAL
Intervention: Smear
Number of subjects: 90
Study 11495267 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture
Number of subjects: 90
Study 9708408 — intervention group
Group type: EXPERIMENTAL
Intervention: C4-V3 PV immunogen
Number of subjects: 10
Study 9708408 — intervention group
Group type: COMPARATOR
Intervention: Incomplete Freund's adjuvant
Number of subjects: 10
Study 9708408 — intervention group
Group type: EXPERIMENTAL
Intervention: C4-V3 PV immunogen and Incomplete Freund's adjuvant
Number of subjects: 10
Study 7568694 — intervention group
Group type: EXPERIMENTAL
Intervention: No incision (test)
Number of subjects: 11
Study 7568694 — intervention group
Group type: COMPARATOR
Intervention: Standard incision (control)
Number of subjects: 11
Study 3267741 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy (10 sessions of 90 minutes each, led by a psychologist and a general practitioner)
Number of subjects: 20
Study 3267741 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 31868550 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25ug alfacalcidol daily for 3 months
Number of subjects: 100
Study 31868550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 30851986 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck Scale for Suicidal Ideation (BSI)
Number of subjects: 221
Study 30851986 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory (BDI)
Number of subjects: 221
Study 30851986 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck Hopelessness Scale (BHS)
Number of subjects: 221
Study 30851986 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide Attempt Self Injury Interview (SASII)
Number of subjects: 221
Study 30851986 — intervention group
Group type: EXPERIMENTAL
Intervention: Pesticide and insecticide use
Number of subjects: 221
Study 29325436 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 100
Study 29325436 — intervention group
Group type: EXPERIMENTAL
Intervention: Schema Therapy
Number of subjects: 100
Study 27482783 — intervention group
Group type: EXPERIMENTAL
Intervention: Test implant
Number of subjects: 57
Study 27482783 — intervention group
Group type: COMPARATOR
Intervention: Control implant
Number of subjects: 57
Study 25451897 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus advisors
Number of subjects: 42
Study 22592546 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming at 2.5% below RCP (S - 2.5%)
Number of subjects: 9
Study 22592546 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming at 2.5% above RCP (S + 2.5%)
Number of subjects: 9
Study 20919669 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous closed-suction drainage (SCSD) applied after fascia closure, removed on postoperative day three.
Number of subjects: 402
Study 20919669 — intervention group
Group type: COMPARATOR
Intervention: No subcutaneous closed-suction drainage (no-drain group).
Number of subjects: 402
Study 20919669 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis for patients with drains who underwent resection of colorectal malignancies or had lower abdominal incisions.
Number of subjects: 402
Study 17592906 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 400 mg/day
Number of subjects: 588
Study 17592906 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 600 mg/day
Number of subjects: 588
Study 17592906 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 800 mg/day
Number of subjects: 588
Study 17592906 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine IR 400 mg/day
Number of subjects: 588
Study 17592906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 588
Study 16157416 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning exercise
Number of subjects: 12
Study 16157416 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening exercise
Number of subjects: 12
Study 16157416 — intervention group
Group type: COMPARATOR
Intervention: Morning control
Number of subjects: 12
Study 16157416 — intervention group
Group type: COMPARATOR
Intervention: Evening control
Number of subjects: 12
Study 11430779 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B complex dietary intake
Number of subjects: 141
Study 11430779 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B complex status
Number of subjects: 141
Study 11430779 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake and status relationship
Number of subjects: 141
Study 11430779 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive multivitamin supplementation
Number of subjects: 141
Study 9216965 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic carbohydrate‐electrolyte beverage (CHO‐E)
Number of subjects: 7
Study 9216965 — intervention group
Group type: COMPARATOR
Intervention: Water placebo (WP)
Number of subjects: 7
Study 9216965 — intervention group
Group type: COMPARATOR
Intervention: Comparison of WP and CHO‐E
Number of subjects: 7
Study 8423261 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex tone with ERB spacing of 0.75, 1.0, 1.25, 1.5, and 2 ERB, central component frequency of 1000 Hz, level of 65 dB SPL.
Number of subjects: 4
Study 8423261 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex tone with ERB spacing of 0.75 ERB.
Number of subjects: 4
Study 8423261 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex tone with ERB spacing increased from 1 to 2 ERBs.
Number of subjects: 4
Study 8423261 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex tone with ERB spacings of 1.25 or less.
Number of subjects: 4
Study 8423261 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex tone with component frequencies above 1000 Hz.
Number of subjects: 4
Study 8423261 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex tone with component frequencies below 1000 Hz.
Number of subjects: 4
Study 8423261 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory filter shapes measured using the notched noise method.
Number of subjects: 4
Study 2821864 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritodrine treatment (intravenous, 2 hours prior to operation)
Number of subjects: 15
Study 2821864 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (control group, same infusion rate as ritodrine)
Number of subjects: 15
Study 2663239 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin, 80 mg/day
Number of subjects: 34
Study 2663239 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin plus Metoprolol
Number of subjects: 34
Study 2663239 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol, 200 mg/day
Number of subjects: 34
Study 31380892 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional coaching intervention (6 coaching sessions)
Number of subjects: 88
Study 31380892 — intervention group
Group type: COMPARATOR
Intervention: Control group (no coaching)
Number of subjects: 88
Study 28143536 — intervention group
Group type: EXPERIMENTAL
Intervention: High resilience women
Number of subjects: 126
Study 28143536 — intervention group
Group type: EXPERIMENTAL
Intervention: Low resilience women
Number of subjects: 126
Study 28143536 — intervention group
Group type: COMPARATOR
Intervention: Spouses of TPL women
Number of subjects: 126
Study 28143536 — intervention group
Group type: EXPERIMENTAL
Intervention: TPL women
Number of subjects: 126
Study 25583832 — intervention group
Group type: EXPERIMENTAL
Intervention: dalfampridine-ER 10 mg twice daily
Number of subjects: 269
Study 25583832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 23362895 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia with ropivacaine 0.1% (Group 1)
Number of subjects: 75
Study 23362895 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia with ropivacaine 0.375% (Group 2)
Number of subjects: 75
Study 23362895 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia with ropivacaine 0.375% for abdominal wall pain and ropivacaine 0.1% for visceral pain (Group 3)
Number of subjects: 75
Study 23362895 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia with target-controlled infusion of propofol and remifentanil
Number of subjects: 75
Study 21459988 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 70
Study 21459988 — intervention group
Group type: COMPARATOR
Intervention: Usual care psychotherapy
Number of subjects: 70
Study 19114908 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight glycemic control (target glycemia, 80‐110 mg/dL)
Number of subjects: 90
Study 19114908 — intervention group
Group type: COMPARATOR
Intervention: Conventional glycemic control (control group, target glycemia, 180‐200 mg/dL)
Number of subjects: 90
Study 19114908 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinolysis inhibition
Number of subjects: 90
Study 16716515 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 0
Study 16716515 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided relaxation
Number of subjects: 0
Study 16716515 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 15562057 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-LCT/MCT 1% 2 mg/kg IV
Number of subjects: 200
Study 15562057 — intervention group
Group type: COMPARATOR
Intervention: Propofol 1% with IV lidocaine pretreatment
Number of subjects: 200
Study 11586195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureteral stents
Number of subjects: 113
Study 11586195 — intervention group
Group type: COMPARATOR
Intervention: No ureteral stents
Number of subjects: 113
Study 9329515 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled formoterol 24 micrograms bid for 4 weeks
Number of subjects: 22
Study 9329515 — intervention group
Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 22
Study 7950723 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal health education
Number of subjects: 688
Study 7950723 — intervention group
Group type: COMPARATOR
Intervention: Control (no education)
Number of subjects: 688
Study 3297528 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprodian plus rifampicin
Number of subjects: 436
Study 3297528 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprodian plus pyrazinamide
Number of subjects: 436
Study 3297528 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (isoniazid, streptomycin and pyrazinamide)
Number of subjects: 436
Study 3297528 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-resistant strains
Number of subjects: 436
Study 3297528 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall relapses
Number of subjects: 436
Study 3297528 — intervention group
Group type: EXPERIMENTAL
Intervention: Absconding
Number of subjects: 436
Study 31376016 — intervention group
Group type: EXPERIMENTAL
Intervention: 810-nm laser irradiation
Number of subjects: 34
Study 31376016 — intervention group
Group type: COMPARATOR
Intervention: Sham laser (laser in off mode)
Number of subjects: 34
Study 30927057 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 45
Study 30927057 — intervention group
Group type: EXPERIMENTAL
Intervention: MAD
Number of subjects: 45
Study 28594800 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 95
Study 28594800 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate
Number of subjects: 95
Study 28594800 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 95
Study 25748562 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 400 or 800 mg pretreatment with intravenous fentanyl 0.5 μg/kg (session 1) or 1.0 μg/kg (session 2)
Number of subjects: 0
Study 25748562 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 400 or 800 mg pretreatment
Number of subjects: 0
Study 23239295 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic surgery (SILS-A)
Number of subjects: 50
Study 23239295 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic appendectomy (LAP-A)
Number of subjects: 50
Study 21528468 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified technique for intramedullary femur nail removal
Number of subjects: 9
Study 21528468 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique for intramedullary femur nail removal
Number of subjects: 9
Study 18845283 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynecologic treatment plus somatocognitive therapy
Number of subjects: 40
Study 18845283 — intervention group
Group type: COMPARATOR
Intervention: Standard gynecologic treatment
Number of subjects: 40
Study 16494569 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupplemented children with autism
Number of subjects: 35
Study 16494569 — intervention group
Group type: COMPARATOR
Intervention: Unsupplemented control subjects
Number of subjects: 35
Study 12934203 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar resurfacing
Number of subjects: 100
Study 12934203 — intervention group
Group type: COMPARATOR
Intervention: No patellar resurfacing
Number of subjects: 100
Study 12934203 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 10998313 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 100
Study 9148356 — intervention group
Group type: COMPARATOR
Intervention: Balanced anesthesia with isoflurane (expiratory fraction between 0.5% and 0.6%)
Number of subjects: 24
Study 9148356 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol infusion (12 to 6 mg/kg/h)
Number of subjects: 24
Study 8416664 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin supplement (10 mg pyridoxal, 1.0 mg folic acid, 0.4 mg cyanocobalamin)
Number of subjects: 44
Study 8416664 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B-6, B-12, and folate nutritional status
Number of subjects: 44
Study 8416664 — intervention group
Group type: COMPARATOR
Intervention: Suboptimal vitamin status
Number of subjects: 44